half sinemet pr.tab (25+100)mg
ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - levodopa; carbidopa - pr.tab (ΔΙΣΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - (25+100)mg - levodopa; carbidopa - levodopa and decarboxylase inhibitor
vidilac ey.sol.sd 1,6mg/0,5ml sing.dos
bausch + lomb ireland limited, ireland 3013 lake drive, d24ppt dublin + 48 539 772 299 - hypromellose - ey.sol.sd (ΚΟΛΛΥΡΙΟ ΔΙΑΛΥΜΑ ΜΙΑΣ ΔΟΣΗΣ) - 1,6mg/0,5ml sing.dos - hypromellose 1,6mg - hypromellose
lamisil once 1% cutaneous solution
haleon hellas single member societe anonyme (trading as haleon hellas) (0000012468) 274 kifissias avenue , chalandri, athens, 15232 - terbinafine hydrochloride - cutaneous solution - 1% - terbinafine hydrochloride (8000001212) 11,25mg - terbinafine
panadol 500mg film coated tablets
haleon hellas single member societe anonyme (trading as haleon hellas) (0000012468) 274 kifissias avenue , chalandri, athens, 15232 - paracetamol - film coated tablets - 500mg - paracetamol (0000103902) 500mg - paracetamol
panadol advance 500mg film coated tablets
haleon hellas single member societe anonyme (trading as haleon hellas) (0000012468) 274 kifissias avenue , chalandri, athens, 15232 - paracetamol - film coated tablets - 500mg - paracetamol (0000103902) 500mg - paracetamol
panadol soluble 500mg effervescent tablet
haleon hellas single member societe anonyme (trading as haleon hellas) (0000012468) 274 kifissias avenue , chalandri, athens, 15232 - paracetamol - effervescent tablet - 500mg - paracetamol (0000103902) 500mg - paracetamol
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
prizelip f.c.tab 40mg/tab
pharma therapis ΜΟΝΟΠΡΟΣΩΠΗ Ι.Κ.Ε. Δ.Τ. pharma therapis single member p.c. Σημαιοφόρου Έκτορος Γιαλοψού 36, 13123 Ίλιον Αττικής 2105229779 - simvastatin - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 40mg/tab - simvastatin 40mg - simvastatin
fluzomic caps 150mg/cap
pharma therapis ΜΟΝΟΠΡΟΣΩΠΗ Ι.Κ.Ε. Δ.Τ. pharma therapis single member p.c. Σημαιοφόρου Έκτορος Γιαλοψού 36, 13123 Ίλιον Αττικής 2105229779 - fluconazole - caps (ΚΑΨΑΚΙΟ, ΣΚΛΗΡΟ) - 150mg/cap - fluconazole 150mg - fluconazole